BEIJING, June 27, 2011 /PRNewswire-Asia-FirstCall/ —
Dehaier Medical Systems Ltd. (NASDAQ: DHRM)
(“Dehaier” or the “Company”), an emerging leader in the
development, assembly, marketing and sale of medical devices and
homecare medical products in China, today announced that it was
granted three new patents by State Intellectual Property Office of
the People’s Republic of China (“SIPO”). The patent awards were
related to the design of Dehaier’s Sleep Diagnostic and Continuous
Positive Airway Pressure (“CPAP”) homecare medical products and
Medical-grade Air Compressor. These patents were issued in June
2011 and are valid for 10 years.
(Logo:
http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO)
Design patents are granted to products that incorporate unique
shapes, patterns, colors or combinations of features that
strengthen a product’s brand value upon commercialization.
According to Patent Law of People’s Republic of China, design
patents are protected and defensible under national Intellectual
Property Law.
“Innovation through continued R&D is key to supporting
growth in our self-branded homecare business, and we believe these
patent awards further protect our ability to provide the market
with proprietary best-in-breed products. Developing new designs and
enriching self-branded product offerings in the homecare segment is
one of our key growth strategies to meet diversified market needs
with portable, personalized and differential products,” said Mr.
Ping Chen, CEO of Dehaier, “These new patents bring our total
intellectual property holdings to five patents and five software
copyrights, in addition to other proprietary technology, such as
trade secrets. Additionally, we currently have three pending
patents and six pending software copyrights applications with SIPO
for homecare products. We will continue to strengthen our R&D
capabilities and plan to continue to build our intellectual
property portfolio to increase ou
‘/>”/>